Two ORL Faculty Members Receive 2012 Dean’s Teaching Excellence Award
Samer Fakhri, MD, FACS, FRCS(C), an associate professor and residency program director in the Department of Otorhinolaryngology-Head and Neck Surgery at The University of Texas Health Science Center at Houston (UTHealth) Medical School, has been recognized with the medical school’s…
Chair of Otorhinolaryngology Named to Texas Super Doctors 2012 List
Martin J. Citardi, MD, who specializes in the treatment of complicated sinus and nasal diseases and is a core member of the Texas Sinus Institute and Texas Skull Base Physicians, has been named to the 2012 Texas Super Doctors list…
Robotic Surgery Offers New Hope for Throat Cancer Patients
Ron Karni, MD uses a surgical robot for the excision of tonsil and hypopharyngeal (throat) cancers. Click here for more info. Posted May 4, 2012.
Using Cord Blood Stem Cells to Potentially Treat Hearing Loss
Click here for more info. Posted March 19, 2012.
Allergy Season Arrives in the Houston Area With A Fury
Amber Luong, MD, PhD comments upon the early arrival of spring allergies in 2012. Click here for more info. Posted March 5, 2012.
Cord Blood Stem Cell Clinical Trial For Hearing Loss begins
The phase I clinical trial, the first cord blood trial to be given the go-ahead by the US Food and Drug Administration (FDA), will determine the safety of the treatment. The team from the Children’s Memorial Hermann Hospital in Houston…
Stem Cells To Be Studied as Fix for Hearing Loss in Kids
Hearing loss study will utilize stem cells from a patient’s own cord blood. Dr. Samer Fakhri, lead investigator, explains details of the study. Click here for more info. February 10, 2012.
Study Testing Stems Cells for Hearing Loss
Researchers have been given the go-ahead to test stems cells from cord blood with the ultimate goal of reversing hearing loss in infants and toddlers. Posted February 9, 2012.
FDA-Approved Study Will Use Cord Blood Stem Cells to Treat Sensorineural Hearing Loss in Children
Children’s Memorial Hermann Hospital and Cord Blood Registry are launching the first phase I safety study approved by the U.S. Food and Drug Administration on the use of cord blood stem cells to treat children with sensorineural hearing loss. Click…
Hospital Begins First Stem Cells Approved Study to Treat Hearing Loss
The first FDA-approved study of stem cells to treat hearing loss begins at Children’s Memorial Hermann Hospital. Click here for more info. Posted January 26, 2012.